Log In
Print
BCIQ
Print
Print this Print this
 

imetelstat (GRN163L)

  Manage Alerts
Collapse Summary General Information
Company Geron Corp.
DescriptionOligonucleotide that competitively inhibits telomerase activity
Molecular Target Telomerase
Mechanism of ActionTelomerase inhibitor
Therapeutic ModalityNucleic acid: Linear RNA: Antisense

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$935.0M

$35.0M

$900.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today